Computational Methods Reveal How Hospital-Acquired Bacteria Spread

Scientists at the Academy of Finland's Centre of Excellence in Computational Inference Research have developed novel computational methods that have yielded essential knowledge of how hospital-acquired bacteria spread and develop. These new methods, based on randomised algorithms, make it possible to analyse extensive genomic data significantly faster and more efficiently than previously. By applying these results, it is possible to better follow hospital-acquired infections in the future, or even fight them in real time.

The new methods are used to develop models of the evolution of bacteria and viruses. "Essential for the evolution of the bacteria that cause hospital-acquired infections is the horizontal gene transfer. It means that several different cell processes transfer genes between the lineages of the same and different species so that the bacterium becomes resistant to antibiotics and the virulence factor rapidly spreads in the population," explains group leader, Professor Jukka Corander. Corander's group is part of the Centre of Excellence in Computational Inference Research.

This so-called recombination of bacteria makes it much more complicated to carry out evolution analyses. To facilitate such analyses, Corander's group in cooperation with researchers from Harvard University and the Wellcome Trust Sanger Institute has developed a number of methods based on smart randomised algorithms. These methods facilitate efficient and reliable analyses of extensive genomic data. With the current, most commonly used computational methods this work would take several months or even several years.

Two of the group's methods have recently been applied by an international study. This study demonstrated that more than half of the genetic variation of the MRSA bacteria (i.e. methicillin-resistant strains of Staphylococcus aureus) is caused by horizontal genomic transfer. This shows that the evolutionary analyses of the strains of bacteria are necessary when investigating the spread of bacteria in a host population. This horizontal variation significantly distorts the results received from normal evolutionary analyses.

"On the basis of the results from these analyses, i.e. the evolutionary variation, we're able to estimate when a certain strain of the MRSA bacterium has entered a country and started to spread to hospitals. This is the first time we have been able to prove that the interplay between the horizontal genomic variation and the mutational genomic variation may vary significantly across geographical locations and even between individual hospitals," Corander says. According to Corander, these insights open up new opportunities for in-depth studies on the spread and variation of MRSA and related causalities.

In another recently published study, Corander's group investigated the origin and evolution of the Enterococcus faecium bacterium that has adapted to survive in hospital environments. By using its analysis methods, the group found out that the forms of the bacteria originate from several independent sources, which is contrary to previous knowledge. In the nuclear genome of hospital strains of E. faecium, fewer signs of horizontal transfer were found than expected. This discovery led to a hypothesis that strains of bacteria that have adapted to survive in hospital environments may become either genetically or ecologically more isolated after horizontal transfer.

MRSA is a globally spread bacterium that is especially troublesome in hospitals. It is resistant to most antibiotics and annually causes the death of tens of thousands of people in the US, for instance. According to cautious estimates, the annual costs incurred by MRSA infections amount to several billion US dollars. In recent years, the E. faecium bacterium has become one of the major causes of hospital-acquired infections and its antibiotic-resistant strains have caused severe hospital epidemics worldwide.

Santiago Castillo-Ramirez, Jukka Corander, Pekka Marttinen, Mona Aldeljawi, William P Hanage, Henrik Westh, Kit Boye, Zeynep Gulay, Stephen D Bentley, Julian Parkhill, Matthew T Holden and Edward J Feil
Phylogeographic variation in recombination rates within a global clone of Methicillin-Resistant Staphylococcus aureus (MRSA) Genome Biology, 13:R126 doi:10.1186/gb-2012-13-12-r126.

Rob J. L. Willems, Janetta Top, Willem van Schaik, Helen Leavis, Marc Bonten, Jukka Sirén, William P Hanage and Jukka Corander
Restricted gene flow among hospital subpopulations of Enterococcus faecium. mBio, 3, e00151-12.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...